Halide perovskite nanocrystals are promising materials for optoelectronic devices due to their outstanding opto-electrical properties. However, achieving stable blue emission with high photoluminescence quantum yield remains challenging because of halide segregation and surface defects. Dopamine hydrochloride was used as a bi-functional reagent to simultaneously facilitate both Br⁻/Cl⁻ halide exchange and surface defect passivation. As the post-treatment time increased, the photoluminescence spectrum of CsPb(Br1-xClx)3 nanocrystals was blue-shifted from ~512 nm to ~478 nm, and photoluminescence quantum yield increased from ~56.4 ± 2.1% to ~75.5 ± 2.9%. The X-ray photoelectron spectroscopy results revealed that metallic Pb0 was effectively passivated by dopamine, resulting in the recovery of photoluminescence quantum yield. The reactivity of dopamine hydrochloride was pH-dependent. Under mildly acidic conditions, dopamine hydrochloride did not effectively dissociate to generate Cl⁻ ions, minimizing bandgap change and inhibiting the formation of polydopamine. In contrast, under mildly basic conditions, both Br⁻/Cl⁻ halide exchange and formation of polydopamine proceeded efficiently. The CsPb(Br1-xClx)3 nanocrystals retained ~59.4% of their initial photoluminescence intensity under moisture exposure, demonstrating superior structural stability. This work demonstrates that dopamine hydrochloride post-treatment enables blue-emitting CsPb(Br1–xClx)3 nanocrystals with high photoluminescence quantum yield and excellent structural stability through halide exchange and surface defect passivation. Dokyum Kim and colleagues report a post-treatment strategy using dopamine hydrochloride to simultaneously enable halide exchange and surface defect passivation in CsPbBr3 NCs. This work addresses a key challenge in halide perovskite nanocrystal (PNC) research, where wavelength tuning and structural stability are achieved through separate or multi-step surface engineering processes.
Kim et al. (2026) studied this question.